Search

everythinglearnresearchcommunity

for

Search:↓

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

Women with hair loss may have higher heart disease risk.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Thorough scalp examination is crucial for diagnosing alopecia areata incognita in men with diffuse hair loss.

Anabolic steroid misuse is a major health issue causing severe health problems and requires better awareness and monitoring.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

The treatment showed promising hair regrowth in advanced-stage hair loss.

People with androgenetic alopecia have a higher risk of heart disease.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

AGA more common in men, Koreans have lower rates and unique patterns.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

PRP therapy improves hair growth safely in androgenetic alopecia but needs standardized methods.

Unani treatment significantly regrows hair in young adults with androgenetic alopecia.

PRP therapy is a promising and effective treatment for hair loss with minimal side effects.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Standardized PRP therapy can improve treatment for hair loss.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.